Oncopeptides AB (publ) (LON:0RN4)
London flag London · Delayed Price · Currency is GBP · Price in SEK
1.492
+0.012 (0.81%)
At close: Feb 21, 2025

Oncopeptides AB Market Cap

Oncopeptides AB has a market cap or net worth of 24.09 million as of February 21, 2025. Its market cap has decreased by -49.23% in one year.

Market Cap
24.09M
Enterprise Value
14.21M
Revenue
1.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.49

Market Cap Chart

Since February 22, 2017, Oncopeptides AB's market cap has decreased from 149.07M to 24.09M, a decrease of -83.84%. That is a compound annual growth rate of -20.37%.

History

DateMarket Cap% Change
Feb 21, 202524.09M-0.58%
Dec 30, 202424.23M-57.05%
Dec 29, 202356.41M-38.17%
Dec 30, 202291.23M76.11%
Dec 30, 202151.80M-94.99%
Dec 30, 20201.03B80.19%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 179.71B
Shell 164.13B
HSBC Holdings 156.44B
Unilever 110.18B
Rio Tinto Group 85.95B
RELX PLC 73.75B
BP p.l.c. 70.76B
British American Tobacco p.l.c. 66.72B
Market Cap Rankings